---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-26-000934"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2026-07-07T21:00:11+00:00"
generated_at: "2026-07-07T21:02:06.534733+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# TOI secures $75M OrbiMed term loan, repays $86M Deerfield convertible note

## Summary
- $75M term loan from OrbiMed, matures 2031, interest at SOFR+5.75% (floor 3%).
- Repaid $86M Deerfield 4% senior secured convertible note using loan and ~$11M cash.
- Issued warrants for 10,025,535 shares at $8.567 to Deerfield as part of repayment.
- No new equity raised; transaction improves liquidity and extends debt maturities.
- Covenant requires minimum net revenue of $700M for trailing 12 months starting Dec 2027.

## SEC filing metadata
- accession: 0001079973-26-000934
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2026-07-07T21:00:11+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000107997326000934/0001079973-26-000934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000107997326000934/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-26-000934
- JSON: https://secwatch.observer/filing/0001079973-26-000934.json
- Plain text: https://secwatch.observer/filing/0001079973-26-000934.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.